(Q35215068)

7 August 2017

1 reference

title

Treatment of hypertension in older patients: an updated look at the role of calcium antagonists (English)

1 reference

7 August 2017

John B Kostis

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

The American Journal of Geriatric Cardiology

7 August 2017

published in

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

319-327

1 reference

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Matching the right drug to the right patient in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Antihypertensive therapy in the geriatric patient. I: A review of the role of calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Calcium channel blockers in treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Antihypertensive drug therapy in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2003.01722.X

10.1111/J.1076-7460.2003.01722.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference